Design of Non-Haemolytic Nanoemulsions for Intravenous Administration of Hydrophobic APIs by Line Séguy, Anne-Claire Groo, Didier Goux, Didier Hennequin, Aurélie Malzert-Fréon

Get full text

Active Targeted Nanoemulsions for Repurposing of Tegaserod in Alzheimer’s Disease Treatment by Line Séguy, Léna Guyon, Manon Maurel, Pascal Verdié, Audrey Davis, Sophie Corvaisier, Vincent Lisowski, Patrick Dallemagne, Anne-Claire Groo, Aurélie Malzert-Fréon

Get full text

Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer’s Disease Treatment by Thomas Adnet, Anne-Claire Groo, Céline Picard, Audrey Davis, Sophie Corvaisier, Marc Since, Frédéric Bounoure, Christophe Rochais, Loïc Le Pluart, Patrick Dallemagne, Aurélie Malzert-Fréon

Get full text

NA1—115—7, from Zygogynum pancheri, is a new selective MCL-1 inhibitor inducing the apoptosis of hematological cancer cells but non-toxic to normal blood cells or cardiomyocytes... by Florian Daressy, Line Séguy, Loëtitia Favre, Sophie Corvaisier, Cécile Apel, Anne-Claire Groo, Marc Litaudon, Vincent Dumontet, Aurélie Malzert-Fréon, Sandy Desrat, Fanny Roussi, Aude Robert, Joëlle Wiels

Get full text